Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Nov. 30, 2021	Nov. 30, 2020
Statement of Cash Flows [Abstract]
Net income (loss)	$ (3,369,192)	$ 1,527,562
Adjustments to reconcile net loss to cash used in operating activities
Depreciation	6,224	297
Gain on write-off of liabilities	(4,292)	(3,585,639)
Forgiveness of PPP loan	(75,104)
Stock-based compensation expense	336,266	193,750
Changes in working capital assets and liabilities:
Inventory	(97,222)	(15,129)
Other current assets	(84,380)	(34,300)
Accounts payable and accrued expenses	389,322	(181,026)
Accrued interest on notes payable	804,233	847,987
Operating lease liability	53,865
Cash used in operating activities	(1,966,781)	(1,246,498)
Cash used in investing activities:
Purchase of property, plant and equipment	(116,844)	(8,921)
Cash flows from financing activities:
Issuance of common stock	1,867,755	1,220,000
Principal payments of notes payable	(95,572)	(65,000)
Proceeds from Federal PPP loans	91,235	224,305
Cash provided by financing activities	1,863,418	1,379,305
Net increase (decrease) in cash and cash equivalents	(220,207)	123,886
Beginning cash	390,702	19,807
Ending cash	170,494	143,693
Cash paid in the period for:
Interest	89,846	2,500
Income taxes
Supplemental schedule of non-cash transactions:
Accounts payable converted into shares of common stock	450,000
Accrued expenses converted into shares of common stock	100,000
Notes payable converted into shares of common stock		267,000
Acquire fixed asset with note payable	$ 209,666